SLG
62
-4
PAYX
57
-2
ADM
24
2
EMN
50
-2
LRCX
46
-2
PSX
47
3
HRL
30
-3
RCL
88
-2
UHS
54
-4
DLTR
40
4
STI
31
19
T
48
3
ADI
45
-5
LEG
31
3
AAPL
45
3
STX
52
-4
AIG
47
6
DVA
72
-3
SYY
47
-2
NWSA
71
-2
SLG
62
-4
PAYX
57
-2
ADM
24
2
EMN
50
-2
LRCX
46
-2
PSX
47
3
HRL
30
-3
RCL
88
-2
UHS
54
-4
DLTR
40
4
STI
31
19
T
48
3
ADI
45
-5
LEG
31
3
AAPL
45
3
STX
52
-4
AIG
47
6
DVA
72
-3
SYY
47
-2
NWSA
71
-2
Financhill
Back

Rocket Lab USA 10K Form

Buy
88

RKLB
Rocket Lab USA

Last Price:
18.02
Seasonality Move:
-13.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RKLB News And Ratings

See the #1 stock for the next 7 days that we like better than RKLB

RKLB Financial Statistics

Sales & Book Value

Annual Sales: $244.59M
Cash Flow: $-28.34M
Price / Cash Flow: 0
Annual Sales: $0.92
Price / Book: 16

Profitability

EPS (TTM): -0.35000
Net Income (TTM): $-176.96M
Gross Margin: $51.41M
Return on Equity: -32.95%
Return on Assets: -16.87%

Rocket Lab USA Earnings Forecast

Key Rocket Lab USA Financial Ratios

  • The Gross Profit Margin over the past 4 years for RKLB is 21.02%.
  • The Selling, General & Administrative Expenses for RKLB have been equal to 45.08% of Gross Profit Margin.
  • The Research & Development expenses have been 48.67% of Revenue.
  • The Interest Expense is -5.74% of Operating Income.
  • The Net Earning history of RKLB is -74.64% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

Rocket Lab USA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Aerospace & Defense
Sector: Industrials
Current Symbol: RKLB
Website: rocketlabusa.com

Debt

Debt-to-Equity Ratio: 0.89
Current Ratio: 2.82
Quick Ratio: 2.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RKLB Technical Analysis vs Fundamental Analysis

Buy
88
Rocket Lab USA (RKLB) is a Buy

Is Rocket Lab USA a Buy or a Sell?

  • Rocket Lab USA stock is rated a Buy
    The current Rocket Lab USA [RKLB] share price is $18.81. The Score for RKLB is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.